Erin E Bonar1, Rebecca M Cunningham2, Emily C Sweezea3, Frederic C Blow4, Laura E Drislane5, Maureen A Walton6. 1. Addiction Center, Department of Psychiatry, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 16, Ann Arbor, MI, 48109, USA; Injury Prevention Center, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 10, Ann Arbor, MI, 48109, USA; Center for Sexuality and Health Disparities, University of Michigan, 400 North Ingalls Street, Ann Arbor, MI, 48109, USA. Electronic address: erinbona@med.umich.edu. 2. Injury Prevention Center, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 10, Ann Arbor, MI, 48109, USA; Department of Emergency Medicine, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 10, Ann Arbor, MI, 48109, USA; Department of Health Behavior and Health Education, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI, 48109, USA; Emergency Medicine, Hurley Medical Center, 1 Hurley Plaza, Flint, MI, 48503, USA. 3. Addiction Center, Department of Psychiatry, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 16, Ann Arbor, MI, 48109, USA. 4. Addiction Center, Department of Psychiatry, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 16, Ann Arbor, MI, 48109, USA; VA Center for Clinical Management Research, North Campus Research Complex, 2800 Plymouth Rd Bldg 16, Ann Arbor, MI, 48109-2800, USA. 5. Addiction Center, Department of Psychiatry, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 16, Ann Arbor, MI, 48109, USA; Department of Psychology and Philosophy, Sam Houston State University, 1901 Avenue I, Huntsville, TX, 77340, USA. 6. Addiction Center, Department of Psychiatry, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 16, Ann Arbor, MI, 48109, USA; Injury Prevention Center, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Building 10, Ann Arbor, MI, 48109, USA.
Abstract
PURPOSE: There are few efficacious prevention interventions for emerging adults (ages 18-25) drug use and concomitant risks (e.g., sexual risk behaviors). We developed and evaluated the feasibility and acceptability of an Emergency Department (ED)-initiated brief intervention (BI) combined with booster messaging as a clinician-extender primarily focusing on drug use, with a secondary focus on condomless sex. We examined descriptive outcomes of alcohol, drug use, and condomless sex. PROCEDURES: We recruited N = 63 emerging adults who used drugs (primarily cannabis) from an ED (72.4 % participation rate). Their mean age was 21.7 years (SD = 2.3); 67 % were female and 52.4 % were Black/African American. Participants randomized to the intervention (N = 31) received a BI and 28 days of tailored booster messaging (based on drug use motives) daily, and the control condition received a community resource brochure. A post-test occurred at 1-month with a follow-up at 2-months. RESULTS: The intervention was well-received (83.9 % allocated completed the BI) with 79 % overall liking the BI and 71 % finding it helpful to discuss substances. Mean ratings of booster messages were >4.0 (5-point scale); 77 % liked the daily messages and 91 % found them helpful. Descriptively, the intervention group evidenced absolute reductions over time on alcohol outcomes, cannabis use, and condomless sex. CONCLUSIONS: This BI with booster messages was feasible and acceptable in the target population of emerging adults who use drugs (i.e., mostly cannabis). This intervention model, initiated during a healthcare visit and accompanied by a clinician-extender, should be tested in a future fully-powered trial.
PURPOSE: There are few efficacious prevention interventions for emerging adults (ages 18-25) drug use and concomitant risks (e.g., sexual risk behaviors). We developed and evaluated the feasibility and acceptability of an Emergency Department (ED)-initiated brief intervention (BI) combined with booster messaging as a clinician-extender primarily focusing on drug use, with a secondary focus on condomless sex. We examined descriptive outcomes of alcohol, drug use, and condomless sex. PROCEDURES: We recruited N = 63 emerging adults who used drugs (primarily cannabis) from an ED (72.4 % participation rate). Their mean age was 21.7 years (SD = 2.3); 67 % were female and 52.4 % were Black/African American. Participants randomized to the intervention (N = 31) received a BI and 28 days of tailored booster messaging (based on drug use motives) daily, and the control condition received a community resource brochure. A post-test occurred at 1-month with a follow-up at 2-months. RESULTS: The intervention was well-received (83.9 % allocated completed the BI) with 79 % overall liking the BI and 71 % finding it helpful to discuss substances. Mean ratings of booster messages were >4.0 (5-point scale); 77 % liked the daily messages and 91 % found them helpful. Descriptively, the intervention group evidenced absolute reductions over time on alcohol outcomes, cannabis use, and condomless sex. CONCLUSIONS: This BI with booster messages was feasible and acceptable in the target population of emerging adults who use drugs (i.e., mostly cannabis). This intervention model, initiated during a healthcare visit and accompanied by a clinician-extender, should be tested in a future fully-powered trial.
Authors: Erin E Bonar; Lauren K Whiteside; Maureen A Walton; Marc A Zimmerman; Brenda M Booth; Frederic C Blow; Rebecca Cunningham Journal: J HIV AIDS Soc Serv Date: 2014-06-01
Authors: Kipling M Bohnert; Maureen A Walton; Megan Ranney; Erin E Bonar; Frederic C Blow; Marc A Zimmerman; Brenda M Booth; Rebecca M Cunningham Journal: Addict Behav Date: 2014-09-28 Impact factor: 3.913
Authors: Erin E Bonar; Maureen A Walton; Quyen M Epstein-Ngo; Marc A Zimmerman; Frederic C Blow; Rebecca M Cunningham Journal: AIDS Behav Date: 2017-07
Authors: Erin E Bonar; Lara Coughlin; Jessica S Roche; Meredith L Philyaw-Kotov; Emily A Bixler; Sergey Sinelnikov; Alaina Kolosh; Morgan J Cihak; Rebecca M Cunningham; Maureen A Walton Journal: Prev Med Date: 2020-01-03 Impact factor: 4.018
Authors: Jessica S Roche; Michael J Clery; Patrick M Carter; Aaron Dora-Laskey; Maureen A Walton; Quyen M Ngo; Rebecca M Cunningham Journal: Acad Emerg Med Date: 2018-10-31 Impact factor: 3.451
Authors: Erin E Bonar; Rebecca M Cunningham; R Lorraine Collins; James A Cranford; Stephen T Chermack; Marc A Zimmerman; Frederic C Blow; Maureen A Walton Journal: Addict Res Theory Date: 2017-04-05
Authors: Lara N Coughlin; Erin E Bonar; Amy S B Bohnert; Frederic C Blow; José A Bauermeister; Yazmyn Cross; Rebecca Cunningham; Sean D Young; Maureen A Walton Journal: Addict Res Theory Date: 2021-06-24
Authors: Erin E Bonar; Kelley M Kidwell; Amy S B Bohnert; Carrie A Bourque; Patrick M Carter; Sarah J Clark; Meyer D Glantz; Cheryl A King; Eve D Losman; Sean Esteban McCabe; Meredith L Philyaw-Kotov; Lisa A Prosser; Terri Voepel-Lewis; Kai Zheng; Maureen A Walton Journal: Contemp Clin Trials Date: 2021-08-02 Impact factor: 2.261